Psychopharmacologic Treatment of Schizophrenia in Adolescents and Children

Esther S. Lee, Hal Kronsberg, Robert L. Findling

Research output: Contribution to journalReview articlepeer-review

Abstract

An increasing number of antipsychotic medications have demonstrated efficacy in randomized placebo-controlled trials in the treatment of children and adolescents with schizophrenia. This review summarizes and synthesizes relevant antipsychotic medication studies, with particular emphasis on second-generation agents, and discusses other clinical considerations that may influence medication selection. With the exception of clozapine demonstrating superior efficacy in the improvement of psychotic symptoms in treatment-resistant patients, many antipsychotic agents have been shown to be similarly efficacious, including first-generation medications. Consideration of the side-effect profile, which can differ substantially from medication to medication, is essential when choosing treatment options.

Original languageEnglish (US)
Pages (from-to)183-210
Number of pages28
JournalChild and Adolescent Psychiatric Clinics of North America
Volume29
Issue number1
DOIs
StatePublished - Jan 2020

Keywords

  • Adolescents
  • Antipsychotic medication
  • Antipsychotic side effects
  • Children
  • Psychopharmacology
  • Psychosis
  • Schizophrenia

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Psychopharmacologic Treatment of Schizophrenia in Adolescents and Children'. Together they form a unique fingerprint.

Cite this